CA2254862A1 - Metabotropic gaba[b] receptors, receptor-specific ligands and their uses - Google Patents

Metabotropic gaba[b] receptors, receptor-specific ligands and their uses Download PDF

Info

Publication number
CA2254862A1
CA2254862A1 CA002254862A CA2254862A CA2254862A1 CA 2254862 A1 CA2254862 A1 CA 2254862A1 CA 002254862 A CA002254862 A CA 002254862A CA 2254862 A CA2254862 A CA 2254862A CA 2254862 A1 CA2254862 A1 CA 2254862A1
Authority
CA
Canada
Prior art keywords
leu
ser
receptor
val
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002254862A
Other languages
English (en)
French (fr)
Inventor
Klemens Kaupmann
Bernhard Bettler
Helmut Bittiger
Wolfgang Frostl
Stuart John Mickel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2254862A1 publication Critical patent/CA2254862A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301Acyclic saturated acids which can have further substituents on alkyl
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002254862A 1996-05-30 1997-03-19 Metabotropic gaba[b] receptors, receptor-specific ligands and their uses Abandoned CA2254862A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US65571696A 1996-05-30 1996-05-30
US08/655,716 1996-05-30
US75609196A 1996-11-22 1996-11-22
US08/756,091 1996-11-22

Publications (1)

Publication Number Publication Date
CA2254862A1 true CA2254862A1 (en) 1997-12-11

Family

ID=27097014

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002254862A Abandoned CA2254862A1 (en) 1996-05-30 1997-03-19 Metabotropic gaba[b] receptors, receptor-specific ligands and their uses

Country Status (9)

Country Link
EP (1) EP0907731B1 (enExample)
JP (3) JP4131568B2 (enExample)
AT (1) ATE290079T1 (enExample)
AU (1) AU2028497A (enExample)
CA (1) CA2254862A1 (enExample)
DE (1) DE69732631T2 (enExample)
ES (1) ES2239352T3 (enExample)
PT (1) PT907731E (enExample)
WO (1) WO1997046675A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2308102A1 (en) * 1997-10-27 1999-05-06 Astrazeneca Aktiebolag New nucleotide sequences
JP2002502859A (ja) * 1998-02-05 2002-01-29 メルク エンド カムパニー インコーポレーテッド 新規gabab受容体dna配列
EP0937777A3 (en) * 1998-02-20 1999-11-24 Smithkline Beecham Plc GABA receptors and their uses
EP1066325A1 (en) * 1998-04-03 2001-01-10 Nps Pharmaceuticals, Inc. G-protein fusion receptors and chimeric gaba b? receptors
US7262280B1 (en) 1998-04-03 2007-08-28 Nps Pharmaceuticals, Inc. G-protein fusion receptors and constructs encoding same
WO1999051636A2 (en) * 1998-04-03 1999-10-14 Nps Pharmaceuticals, Inc. Gaba b receptor
WO1999058567A1 (en) * 1998-05-08 1999-11-18 Smithkline Beecham Corporation GABAB1b RECEPTOR
AUPP438498A0 (en) * 1998-06-29 1998-07-23 Garvan Institute Of Medical Research Novel Gaba-B receptor
JP2002523070A (ja) * 1998-09-01 2002-07-30 スミスクライン ビーチャム コーポレーション Gabab1aa受容体
WO2000014222A2 (en) * 1998-09-07 2000-03-16 Glaxo Group Limited GABAB RECEPTOR SUBTYPES GABAB-R1c AND GABAB-R2 AND HETERODIMERS THEREOF
GB9819420D0 (en) 1998-09-07 1998-10-28 Glaxo Group Ltd Novel receptor
GB9906882D0 (en) * 1999-03-25 1999-05-19 Novartis Ag Organic compounds
SE9901659D0 (sv) 1999-05-06 1999-05-06 Astra Ab New methods
US20010053849A1 (en) * 1999-06-16 2001-12-20 Mary Jeanne Kreek Plural biological sample arrays, and preparation and uses thereof
US6787646B1 (en) * 1999-11-12 2004-09-07 Immusol, Inc. Tumor suppressor molecules and methods of use
DE19955408A1 (de) * 1999-11-18 2001-05-23 Bayer Ag GABA-B-Rezeptoren
WO2004083855A1 (en) * 2003-03-19 2004-09-30 Solvo Biotechnology, Inc. Method for the identification of cells specifically modulating slow inhibition in the neocortex
CN102532197A (zh) * 2010-12-24 2012-07-04 中国科学院上海药物研究所 一类光亲和标记双功能探针分子及其制备方法和应用
CN108588087B (zh) * 2018-05-16 2022-06-03 南京农业大学 一种提高植物抗病性的基因GmLecRK-R及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU662404B2 (en) * 1992-05-08 1995-08-31 Novartis Ag Novel N-aralkyl- and N-heteroaralkyl-aminoalkanephosphinic acids

Also Published As

Publication number Publication date
DE69732631D1 (de) 2005-04-07
EP0907731B1 (en) 2005-03-02
ATE290079T1 (de) 2005-03-15
JP2000515005A (ja) 2000-11-14
AU2028497A (en) 1998-01-05
JP4202403B2 (ja) 2008-12-24
JP2008113662A (ja) 2008-05-22
JP2007289188A (ja) 2007-11-08
PT907731E (pt) 2005-07-29
DE69732631T2 (de) 2005-12-29
WO1997046675A1 (en) 1997-12-11
ES2239352T3 (es) 2005-09-16
EP0907731A1 (en) 1999-04-14
JP4131568B2 (ja) 2008-08-13

Similar Documents

Publication Publication Date Title
JP4202403B2 (ja) 代謝調節型gaba[b]レセプター、レセプター特異的リガンドおよびそれらの使用
AU695641B2 (en) Human metabotropic glutamate receptor subtypes (HMR4, HMR6, HMR7) and related DNA compounds
US6201108B1 (en) TGF-β type receptor cDNAs encoded products and uses therefor
RU2146132C1 (ru) Фармацевтическая композиция, активная в отношении рецептора кальция, способ лечения пациента, способ анализа соединения оказывать влияние на активность рецептора неорганического иона, нуклеиновая кислота, кодирующая рецептор, рецептор кальция
HUT76969A (hu) Glutamát receptor
CA2337492A1 (en) Delta-related polypeptides
AU753185B2 (en) Ligand receptors and uses therefor
US6335172B1 (en) Cloned tetrodotoxin-sensitive sodium channel α-subunit and a splice variant thereof
JP2001514487A (ja) 酸性感受性哺乳動物ニュ−ロン陽イオンチャンネル、そのクロ−ニングおよびその用途
US7119189B2 (en) Metabotropic GABA [B] receptors, receptor-specific ligands and their uses
US6750322B2 (en) Guanosine triphosphate (GTP) binding protein-coupled receptor proteins
JPH10504961A (ja) Gaba▲下a▼レセプターイプシロンサブユニット
US6723838B1 (en) Signal transducing synaptic molecules and uses thereof
US6361971B1 (en) Nucleic acid molecules encoding potassium channel interactors and uses therefor
US20030092035A1 (en) Pain signaling molecules
EP0956508B1 (en) Icam-4 and diagnostic uses thereof
US5945509A (en) Glutamate receptor compositions and method
EP1673436A2 (en) Nucleic acid molecules encoding novel human low-voltage activated calcium channel proteins, designated - alpha 1i-1 and alpha 1i-2, encoded proteins and methods of use thereof
AU3897699A (en) Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors
MXPA00007226A (en) Ligand receptors and uses therefor
MXPA01000980A (en) Delta-related polypeptides
MXPA97001267A (en) Glutam receiver
PT1199359E (pt) Subtipos do receptor do glutamato metabotrópico humano (hmr4, hmr6, hmr7) e compostos de dna relacionados

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued